H19 and cancer: Analysis of 667 samples from TCGA exhibited that H19 differential expression was noticeably associated with primary disease, histological type, histologic grade, new tumor event, tumor tissue site, cancer status, primary therapy outcome, radiation therapy, sample type, targeted molecular therapy and age (Figure 10B).